about
Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF)Nonhomologous end joining and V(D)J recombination require an additional factorLymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumoursImmunoglobulin class switch recombination is impaired in Atm-deficient miceMolecular pathology of ataxia telangiectasiaThe molecular pathology of primary immunodeficienciesPotential for bispecific T-cell engagers: role of blinatumomab in acute lymphoblastic leukemiaSapacitabine for cancerCancers Related to Immunodeficiencies: Update and PerspectivesExpression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemiaLoss of p53 Ser18 and Atm results in embryonic lethality without cooperation in tumorigenesisChemopreventive Metabolites Are Correlated with a Change in Intestinal Microbiota Measured in A-T Mice and Decreased CarcinogenesisNo requirement for V(D)J recombination in p53-deficient thymic lymphomaA novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease.A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activationPediatric T-cell prolymphocytic leukemia with an isolated 12(p13) deletion and aberrant CD117 expression.Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescentsSaccharomyces cerevisiae as a model system to define the chromosomal instability phenotype.Atm is dispensable for p53 apoptosis and tumor suppression triggered by cell cycle dysfunction.Immunodeficiency associated with DNA repair defects.Ataxia telangiectasia gene mutations in leukaemia and lymphoma.ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.ATM influences the efficiency of TCRβ rearrangement, subsequent TCRβ-dependent T cell development, and generation of the pre-selection TCRβ CDR3 repertoire.ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytesOligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphomaSensing of intermediates in V(D)J recombination by ATM.Effects of antioxidants on cancer prevention and neuromotor performance in Atm deficient mice.Mantle cell lymphoma is characterized by inactivation of the ATM gene.Chfr and RNF8 synergistically regulate ATM activation.Abnormal development of Purkinje cells and lymphocytes in Atm mutant miceRisk of childhood leukemia associated with diagnostic irradiation and polymorphisms in DNA repair genes.Experimental antioxidant therapy in ataxia telangiectasia.Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma.ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progressionRecombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin LymphomaMutations associated with variant phenotypes in ataxia-telangiectasiaPrimary Diffuse Large B-cell Lymphoma Arising in the Tongue Accompanied by Ataxia-telangiectasia: A Case Report.
P2860
Q21203047-E7127C29-A63D-40C7-889E-B81705276897Q24554076-EBC2FB00-D246-4FCC-94B4-51E9F8233246Q24597674-4A1FAE7A-615F-4C17-88A8-56090A41D8F2Q24647660-8303D4E6-ED47-4586-976F-2263582340DCQ24672363-0DEC529F-42AC-41BF-8DF4-A56DE4C59E47Q24685932-7974FFC7-792C-4801-9728-5359D668BECCQ26764903-7FFF6F73-0210-4AEA-9280-A57344EC90B1Q27024675-4914D206-D242-4776-A2AD-384FCE470447Q28074182-485AA537-C38A-4E4B-B105-FC60047F09CEQ28282628-855D5A7E-254F-4D7B-A90C-D936987C129EQ28477245-B7962E29-31CA-4618-A360-F78F6C182FDEQ28551328-58B59BD8-E73A-462E-A097-54C94C2DE47FQ28594411-0FCC2DDF-6620-474E-B036-D2952BD5201FQ30670040-BFBC9A2D-801E-4BF5-B621-9D007E99B2F2Q30806557-782E62A3-BBF3-45D7-A0A1-664B95E2F371Q30811594-3DBEFC57-EE65-4A88-BF44-17E8939D9CACQ33330300-E940DD0A-170D-4E33-8ACD-8B960F887820Q33404679-E3DBA542-9046-433F-A9E3-E33419753502Q33822062-E52CE8A6-5DFD-4B21-9DCE-F14B5871AEE4Q33924949-E1D94011-0054-4A8B-90BB-F9B49695EC64Q33957801-1C532898-3983-49F5-9899-CA69D5A422EDQ33962066-AFE4478B-0E83-4E02-807D-55D29BA6C3E6Q34295109-A5CC116C-4D1A-4BA7-ACAA-A8BC4DEC8C2BQ34384444-8EEE1433-F9F8-472A-8E9D-56D1A9337ED5Q34692873-2A32E971-FA1B-4D50-BCAE-2271BD663662Q34707611-AA66EF6A-BFE3-482B-894C-380305F2C853Q34983013-EF38BFBE-4F30-4B9A-AA04-D4D8DD5B42E3Q35005088-0E45528D-10CA-41C8-B0C4-5C53AB17425DQ35021217-47C32DC6-94A5-49EB-AA90-087CB555BA6AQ35081325-25EDF823-E044-46E8-92A7-3CCE4241392EQ35089499-64DF20F9-0EE7-44AD-9C56-4EF58B7DA4B4Q35109704-2CCD9C51-5B98-4A52-9610-FD2EF65C5D61Q35135405-C6F59CC5-0171-4B49-BE73-84AF550FFB0FQ35181084-DE5B4367-827D-405A-9745-A6DF90628158Q35197081-80233CF0-E80C-46D4-8868-9E695F4D409EQ35643020-15D12D46-B697-4E44-85A6-300CB3661E1AQ35795447-7EFA6602-3F06-42E9-A82A-AF3B71954EBAQ35823280-3B1318AA-49ED-4F7E-BF81-F3983C0DC53EQ35881927-25E56F5A-DA76-48D0-A19F-6E15286FDE14Q35918343-971ECB75-5DC8-4B7E-B31C-BCB815EC20E6
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Leukemia and lymphoma in ataxia telangiectasia.
@en
type
label
Leukemia and lymphoma in ataxia telangiectasia.
@en
prefLabel
Leukemia and lymphoma in ataxia telangiectasia.
@en
P2093
P1433
P1476
Leukemia and lymphoma in ataxia telangiectasia.
@en
P2093
P304
P407
P577
1996-01-01T00:00:00Z